Divya Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Divya Patel has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Alash’le Abimiku
International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria
1 shared publication Aliyu Gambo
Affiliation Nigeria AIDS Control Agency, Abuja, Nigeria
1 shared publicationAndrew C. Voetsch
Affiliation Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
1 shared publication- Ashley Simon
Division of Parasitic Diseases and Malaria, Global Health Center, Centers for Disease Control and Prevention, Atlanta, USA
1 shared publication - Bharat S. Parekh
Division of Global HIV & TB, CGH, CDC
1 shared publication - Brian A. Kagurusi
Affiliations Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda, National Health Laboratory and Diagnostic Services/Central Public Health Laboratory (NHLDS/CPHL), Kampala, Uganda
1 shared publication
Latest Publications
- Open Access
- 8 August 2024
- Published by Elsevier in IJID Regions
- Vol. 12, 100421
SARS-CoV-2 seroprevalence in people living with HIV in South Sudan
- 8 August 2024
- Published by Elsevier in IJID Regions
- Vol. 12, 100421
Open AccessSARS-CoV-2 seroprevalence in people living with HIV in South Sudan
- Open Access
- 29 July 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (7) , e0000466
Performance of HIV rapid testing algorithm in Nigeria: Findings from a household-based Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS)
Background: The Nigeria AIDS Indicator and Impact Survey (NAIIS), a cross-sectional household survey, was conducted in 2018 with primary objectives to estimate HIV prevalence, HIV-1 incidence, and status of UNAIDS 90-90-90 cascade. We conducted retrospective analysis of the performance of HIV rapid tests and the national HIV testing algorithm used in Nigeria. Methods: The national algorithm included Determine HIV-1/2 as test 1 (T1), Unigold HIV-1/2 as test 2 (T2), and StatPak HIV-1/2 as the tie-breaker test (T3). Individuals reactive with T1 and either T2 or T3 were considered HIV-positive. HIV-positive specimens from the algorithm were further confirmed for the survey using supplemental test Geenius HIV-1/2. If Geenius did not confirm HIV-positive status, HIV-1 Western blot was performed. We calculated the concordance between tests and positive predictive value (PPV) of the algorithm on unweighted data. Results: Of 204,930 participants (ages ≥18 months) 5,103 (2.5%) were reactive on T1. Serial testing of T1 reactive specimens with T2 or if needed by tiebreaker T3 identified 2958 (1.44%) persons as HIV-positive. Supplemental testing confirmed 2,800 (95%) as HIV-positive (HIV-1 = 2,767 [98.8%]; HIV-2 = 5 [0.2%]; dual infections = 22 [0.8%]). Concordance between T1 and T2 was 56.6% while PPV of the national algorithm was 94.5%. Conclusions: Our results show high discordant rates and poor PPV of the national algorithm with a false-positive rate of about 5.5% in the NAIIS survey. Considering our findings have major implications for HIV diagnosis in routine HIV testing services, additional evaluation of testing algorithm is warranted in Nigeria.
- 29 July 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (7) , e0000466
Open AccessPerformance of HIV rapid testing algorithm in Nigeria: Findings from a household-based Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS)
Background: The Nigeria AIDS Indicator and Impact Survey (NAIIS), a cross-sectional household survey, was conducted in 2018 with primary objectives to estimate HIV prevalence, HIV-1 incidence, and status of UNAIDS 90-90-90 cascade. We conducted retrospective analysis of the performance of HIV rapid tests and the national HIV testing algorithm used in Nigeria. Methods: The national algorithm included Determine HIV-1/2 as test 1 (T1), Unigold HIV-1/2 as test 2 (T2), and StatPak HIV-1/2 as the tie-breaker test (T3). Individuals reactive with T1 and either T2 or T3 were considered HIV-positive. HIV-positive specimens from the algorithm were further confirmed for the survey using supplemental test Geenius HIV-1/2. If Geenius did not confirm HIV-positive status, HIV-1 Western blot was performed. We calculated the concordance between tests and positive predictive value (PPV) of the algorithm on unweighted data. Results: Of 204,930 participants (ages ≥18 months) 5,103 (2.5%) were reactive on T1. Serial testing of T1 reactive specimens with T2 or if needed by tiebreaker T3 identified 2958 (1.44%) persons as HIV-positive. Supplemental testing confirmed 2,800 (95%) as HIV-positive (HIV-1 = 2,767 [98.8%]; HIV-2 = 5 [0.2%]; dual infections = 22 [0.8%]). Concordance between T1 and T2 was 56.6% while PPV of the national algorithm was 94.5%. Conclusions: Our results show high discordant rates and poor PPV of the national algorithm with a false-positive rate of about 5.5% in the NAIIS survey. Considering our findings have major implications for HIV diagnosis in routine HIV testing services, additional evaluation of testing algorithm is warranted in Nigeria.